Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Multiple Myeloma Clinical Trials

Protocol Number Title
1999LS060
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2004LS001
MT2003-13 Autologous Transplantation for Multiple Myeloma
2005LS036
MT2005-02 Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
MT2005-10 Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2010LS086
MT2010-12: A First-in Humans,single-center,open-label, proof-of concept-study to evaluate the safety and tolerability of infusing HSC835 (LFU835-expanded Umbilical Cord hematopoietic stem Cells In patients with hematological malignancies
2012LS023
HM2013-12: IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation
2012LS089
MT2012-17R:Safety of Nplate? in Patients Who Have Failed to Achieve Platelet Engraftment Following Umbilical Cord Blood Transplant
2012NTLS024
MT2012-24R Preparative Regimen Exposure-Response Relationships in Nonmyeloablative Stem Cell Transplants: Correlative Pharmacokinetics.
2012OC065
MT2012-11C: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
2013IS043
MT2014-16: A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma (C16014)
2013OC003
Treatment of graft Failure after HSCT
2013OC116
MT2013-33C:REDUCED INTENSITY (RIC) CONDITIONING AND TRANSPLANTATION OF HLA-HAPLOIDENTICAL RELATED BONE MARROW (HAPLO-BM) FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2014CG017
MT2014-05R:A Multi-Center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host DIsease Prevention Compared to Contemporary Controls
2014CG126
MT2014-33R: Continued Long-Term Follow-up and Lenalidomide Maintenance Therapy for Patienst Who have Enrolled on CTN 0702 (CTN 07LT)
2014IS016
HM2014-21: A Study of ALT-803 in Patients with Relapsed or Refractory Multiple Myeloma
2014NTLS071
Family-based studies of susceptibility to early onset disease

17 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on